NOVA:FRA
Novo Nordisk A/S
€ 41.16
arrow_upward
+2.85%(+1.14) Siku 1
23 Jun, 14:10:34 GMT +2 · EUR
search
Alama zote
Siku 1
Siku 5
Mwezi 1
Miezi 6
YTD
Mwaka 1
Miaka 5
ISIZIDI
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya NOVA...
Fungua
€ 39.88
Juu
€ 41.22
Chini
€ 39.88
Mtaji wa soko
161.92B
Wastani wa kiasi cha mauzo
elfu 1.58
Kiasi cha mauzo ya hisa
elfu 1.32
Juu kwa wiki 52
€ 63.90
Chini kwa wiki 52
€ 30.45
Idadi ya wafanyakazi
elfu 68
Fungua
€ 39.88
Juu
€ 41.22
Chini
€ 39.88
Mtaji wa soko
161.92B
Wastani wa kiasi cha mauzo
elfu 1.58
Kiasi cha mauzo ya hisa
elfu 1.32
Juu kwa wiki 52
€ 63.90
Chini kwa wiki 52
€ 30.45
Idadi ya wafanyakazi
elfu 68
Habari
Kutoka kwenye vyanzo vya wavuti
TIKR.com
·
saa 1 iliyopita
Novo Nordisk Stock Jumped 6% on UK Pill Approval: Here’s Where Shares Could Go in 2026
AD HOC NEWS
·
saa 1 iliyopita
Novo Nordisk updates analyst targets, shares stay in S&P 500 focus
AD HOC NEWS
·
saa 1 iliyopita
Novo Nordisk Shares Jump 9% in a Week as Buyback, Pill Approval, and Court Win Converge
Benzinga
·
saa 16 zilizopita
Novo Nordisk Stock Is Surging Monday: What's Driving The Action? - Novo Nordisk (NYSE:NVO)
Wasifu
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28.1% of its shares and a majority of its voting shares.
Novo Nordisk manufactures and markets pharmaceutical products and services, specifically diabetes and obesity medications and devices.
Novo Nordisk employs more than 48,000 people globally, and markets its products in 168 countries. The corporation was created in 1989, through a merger of two Danish companies, which date back to the 1920s. Novo Nordisk is a full member of the European Federation of Pharmaceutical Industries and Associations.
The company was ranked 25th among Fortune's 100 Best Companies to Work For in 2010, and subsequently ranked 72nd in 2014 and 73rd in 2017. In January 2012, Novo Nordisk was named the most sustainable company in the world by the business magazine Corporate Knights, while spin-off company Novozymes was named fourth. It is a leader in the FTSE4Good Index, and the only European company in the top ten. Novo Nordisk is the largest pharmaceutical company in Denmark. Wikipedia
Kuhusu Novo Nordisk A/S
Afisa Mkuu Mtendaji (CEO)Maziar Mike Doustdar
Wafanyakazielfu 67.9
Lilianzishwa21 Des 1923
Makao makuuBagsværd, Capital Region of Denmark, Denmaki
Sekta-
Tovutinovonordisk.com
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi